newsfilter
← Latest News
GlobeNewswire·

Regeneron Reports First Quarter 2026 Financial and Operating Results

First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent® global net sales (recorded by Sanofi) increased 33% to $4.9 billion EYLEA HD® U.S. net sales increased 52% to